The immune checkpoint inhibitors (ICIs), programmed death receptor‐1 (PD‐1)/programmed death‐ligand 1 (PD‐L1) antibodies are effective against many types of cancer.16, 17, 18, 19, 20. The gene discussed is CD274; the disease is cancer.